- Home
- CAN vs NGNE Comparison
CAN vs NGNE Comparison
Compare CAN & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAN
- NGNE
- Stock Information
- Founded
- CAN 2013
- NGNE 2003
- Country
- CAN Singapore
- NGNE United States
- Employees
- CAN N/A
- NGNE N/A
- Industry
- CAN Semiconductors
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- CAN Technology
- NGNE Health Care
- Exchange
- CAN Nasdaq
- NGNE Nasdaq
- Market Cap
- CAN 425.9M
- NGNE 471.1M
- IPO Year
- CAN 2019
- NGNE N/A
- Fundamental
- Price
- CAN $2.14
- NGNE $22.34
- Analyst Decision
- CAN Strong Buy
- NGNE Strong Buy
- Analyst Count
- CAN 4
- NGNE 6
- Target Price
- CAN $3.38
- NGNE $60.80
- AVG Volume (30 Days)
- CAN 20.8M
- NGNE 748.5K
- Earning Date
- CAN 11-20-2024
- NGNE 11-18-2024
- Dividend Yield
- CAN N/A
- NGNE N/A
- EPS Growth
- CAN N/A
- NGNE N/A
- EPS
- CAN N/A
- NGNE N/A
- Revenue
- CAN $229,630,000.00
- NGNE $925,000.00
- Revenue This Year
- CAN $23.60
- NGNE N/A
- Revenue Next Year
- CAN $60.15
- NGNE N/A
- P/E Ratio
- CAN N/A
- NGNE N/A
- Revenue Growth
- CAN N/A
- NGNE N/A
- 52 Week Low
- CAN $0.72
- NGNE $12.49
- 52 Week High
- CAN $3.50
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- CAN 66.06
- NGNE 36.27
- Support Level
- CAN $1.73
- NGNE $14.44
- Resistance Level
- CAN $2.26
- NGNE $27.68
- Average True Range (ATR)
- CAN 0.27
- NGNE 3.12
- MACD
- CAN 0.03
- NGNE -0.59
- Stochastic Oscillator
- CAN 85.54
- NGNE 27.43
About CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment as well as the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.